BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
34 hedge funds and large institutions have $6.34M invested in Baudax Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $9.18M → $6.34M (-$2.84M)
Holders
34
Holding in Top 10
–
Calls
$88K
Puts
$28K
Top Buyers
| 1 | +$3.54M | |
| 2 | +$391K | |
| 3 | +$223K | |
| 4 |
D.E. Shaw & Co
New York
|
+$134K |
| 5 |
Two Sigma Investments
New York
|
+$128K |
Top Sellers
| 1 | -$2.8M | |
| 2 | -$630K | |
| 3 | -$369K | |
| 4 |
CCM
Corsair Capital Management
New York
|
-$345K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$183K |